We recently identified residue L130 of GSKIP as a critical point for binding with GSK3β, and the L130P GSKIP mutant resulted in loss of inhibition of neurite outgrowth in human neuroblastoma SH-SY5Y cells [5]. The gene discussed is GSK3B; the disease is neuroblastoma.